Exogenous group G Streptococcus endophthalmitis following intravitreal ranibizumab injection.

PubWeight™: 0.76‹?›

🔗 View Article (PMC 3437953)

Published in Clin Ophthalmol on August 28, 2012

Authors

Suleyman Kugu1, Mehmet Sahin Sevim, Nilufer Zorlutuna Kaymak, Gurkan Erdogan, Baran Kandemir, Omer Kamil Dogan

Author Affiliations

1: Lutfi Kırdar Kartal Training and Research Hospital, Eye Clinic, Istanbul.

Articles cited by this

Ranibizumab for neovascular age-related macular degeneration. N Engl J Med (2006) 30.63

Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study. Ophthalmology (2009) 6.44

Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1. Am J Ophthalmol (2008) 5.22

A Phase IIIb study to evaluate the safety of ranibizumab in subjects with neovascular age-related macular degeneration. Ophthalmology (2009) 3.76

Evolving guidelines for intravitreous injections. Retina (2004) 3.39

Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab. Retina (2008) 2.72

Prophylaxis of endophthalmitis with topical povidone-iodine. Ophthalmology (1991) 2.37

Bilateral same-day intravitreal injections using a single vial and molecular bacterial screening for safety surveillance. Retina (2012) 2.09

Anti-vascular endothelial growth factor therapy for ocular neovascular disease. Curr Opin Ophthalmol (2007) 2.08

Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinolone clinical trials. Arch Ophthalmol (2009) 2.06

Group G streptococcal bacteremia: clinical study and review of the literature. Rev Infect Dis (1983) 2.00

Anti-VEGF agents in the treatment of neovascular age-related macular degeneration: applying clinical trial results to the treatment of everyday patients. Am J Ophthalmol (2007) 1.65

Intravitreal bevacizumab and ranibizumab for age-related macular degeneration a multicenter, retrospective study. Ophthalmology (2009) 1.43

Bacterial endophthalmitis following sutureless cataract surgery. Arch Ophthalmol (1993) 1.41

Bacteremia due to beta-hemolytic Streptococcus group G: increasing incidence and clinical characteristics of patients. Am J Med (2002) 1.29

Delayed-onset bleb-associated endophthalmitis: clinical features and visual acuity outcomes. Ophthalmology (2002) 1.18

Aggressive management of an epidemic of chronic pseudophakic endophthalmitis: results and literature survey. Br J Ophthalmol (1994) 1.04

Metastatic bacterial endophthalmitis. Arch Intern Med (1985) 0.99

Chronic postoperative endophthalmitis: a review of clinical characteristics, microbiology, treatment strategies, and outcomes. Int J Inflam (2012) 0.98

Bilateral endophthalmitis and ARDS complicating group G streptococcal endocarditis. Lancet (2005) 0.97

Traumatic bleb-associated Group-G beta-haemolytic Streptococcus endophthalmitis. Clin Experiment Ophthalmol (2008) 0.93

Endogenous group G Streptococcus endophthalmitis following a dental procedure. Eur J Ophthalmol (2004) 0.92

Concomitant bilateral intravitreal anti-VEGF injections for the treatment of exudative age-related macular degeneration. Clin Ophthalmol (2010) 0.90

Bilateral intravitreal injection of antivascular endothelial growth factor therapy. Retina (2011) 0.89

Case of endogenous endophthalmitis caused by Streptococcus equisimilis. Clin Ophthalmol (2010) 0.87

Bilateral endophthalmitis as a primary manifestation of Streptococcus dysgalactiae endocarditis and the role of 16S rDNA polymerase chain reaction in identification. Diagn Microbiol Infect Dis (2010) 0.80

Endophthalmitis as presenting symptom of group G streptococcal endocarditis. Infection (1994) 0.78

A devastating ocular pathogen: beta-streptococcus Group G. Cornea (2000) 0.78

Articles by these authors

Modified capsular tension ring implantation in eyes with traumatic cataract and loss of zonular support. J Cataract Refract Surg (2012) 1.39

Incidence of and risk factors for increased intraocular pressure after penetrating keratoplasty. Cornea (2010) 0.99

Congenital ptosis and amblyopia. J Pediatr Ophthalmol Strabismus (2010) 0.89

Outcomes of 23-gauge pars plana vitrectomy and internal limiting membrane peeling with brilliant blue in macular hole. Clin Ophthalmol (2011) 0.89

Comparison of contrast sensitivity and visual acuity between deep anterior lamellar keratoplasty and penetrating keratoplasty in patients with keratoconus. Int J Ophthalmol (2012) 0.87

Toric intraocular Collamer lens for high myopic astigmatism after penetrating keratoplasty. J Cataract Refract Surg (2009) 0.87

The outcome of silicone intubation and tube removal in external dacryocystorhinostomy patients with distal canalicular obstruction. Eur J Ophthalmol (2012) 0.83

Efficacy of long scleral tunnel technique in preventing Ahmed glaucoma valve tube exposure through conjunctiva. Semin Ophthalmol (2013) 0.81

Corneal endothelial cell loss in post-penetrating keratoplasty patients after cataract surgery: phacoemulsification versus planned extracapsular cataract extraction. J Cataract Refract Surg (2011) 0.81

Vitiligo in a Patient Treated with Interferon Alpha-2a for Behçet's Disease. Case Rep Med (2012) 0.80

Effect of Single Intravitreal Bevacizumab on Ophthalmic and Middle Cerebral Arterial Blood Flow in Retinopathy of Prematurity. Ophthalmic Res (2016) 0.80

Therapeutic applications of lotrafilcon a silicone hydrogel soft contact lenses. Eye Contact Lens (2005) 0.79

Primary implant placement with evisceration in patients with endophthalmitis. Am J Ophthalmol (2006) 0.79

Effect of heparin in the intraocular irrigating solution on postoperative inflammation in the pediatric cataract surgery. Clin Ophthalmol (2009) 0.79

The etiological features of anterior uveitis in a Turkish population. Clin Ophthalmol (2012) 0.79

Unilateral lacrimal fistula in a patient with uterus didelphys and renal agenesis. Int Ophthalmol (2012) 0.79

Primary probing for congenital nasolacrimal duct obstruction with manually curved Bowman probes. Clin Ophthalmol (2013) 0.78

Evaluation of macular thickness change after inferior oblique muscle recession surgery. Indian J Ophthalmol (2014) 0.75

The efficacy of the combined procedure in involutional entropion surgery: a comparative study. Korean J Ophthalmol (2013) 0.75

Correlation of Dry Eye Workshop Dry Eye Severity Grading System With Tear Meniscus Measurement by Optical Coherence Tomography and Tear Osmolarity. Eye Contact Lens (2016) 0.75

Corneal biomechanical properties in patients with recurrent anterior uveitis. Ocul Immunol Inflamm (2012) 0.75

A clinical comparison of safety and efficacy in phacoemulsification with versus without ophthalmic viscoelastic device. Semin Ophthalmol (2013) 0.75

The effect of room illumination on the measurement of anterior segment parameters. Eye Contact Lens (2014) 0.75

Pseudallescheria boydii keratitis. J Pediatr Ophthalmol Strabismus (2006) 0.75

Systemic side effects of antiviral therapy in a patient with acute retinal necrosis. Ocul Immunol Inflamm (2013) 0.75

Wide-Field Landers Keratoprothesis in Various Combined Corneal and Vitreoretinal Problems: Twelve-Month Results. Ophthalmic Surg Lasers Imaging Retina (2017) 0.75

Evaluation of the Cornea and Anterior Chamber Morphologic Changes After Penetrating Keratoplasty in Patients With Keratoconus. Eye Contact Lens (2017) 0.75

Inadvertent use of water-based ink instead of trypan blue in cataract surgery. Cutan Ocul Toxicol (2009) 0.75